Alexander Shulgin's drew me this diagram toward the end of his life, due to his failing vision the molecule was almost a blind contour, which resulted in the diisopropylethylamine side chain being attached to the indole 2-position as opposed to the 3-position. Though I imagine this was drawn in error I can't help but see it as a clue, maybe a result of a subconscious interest in the 2-isotryptamines, a synthetically challenging and pharmacologically promising area.
Wednesday, January 21, 2015
[2-(1H-indol-2-yl)ethyl]bis(propan-2-yl)amine
Alexander Shulgin's drew me this diagram toward the end of his life, due to his failing vision the molecule was almost a blind contour, which resulted in the diisopropylethylamine side chain being attached to the indole 2-position as opposed to the 3-position. Though I imagine this was drawn in error I can't help but see it as a clue, maybe a result of a subconscious interest in the 2-isotryptamines, a synthetically challenging and pharmacologically promising area.
Subscribe to:
Posts (Atom)